Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 179.16%90.08M | 177.40%32.27M | -141.05%-41.69M | 918.96%101.56M | -63.82%9.97M | 270.64%27.55M | -167.39%-16.14M | -39.77%23.95M | 540.54%39.77M | -140.41%-9.03M |
| Net interest income | --0 | -100.03%-38 | 14,529.12%119.91K | ---831 | --0 | ---- | ---- | 223.24%1.88K | 28.26%581 | 384.91%453 |
| -Net interest income | --0 | --0 | --119.91K | --0 | --0 | ---- | ---- | 162.94%1.93K | 62.03%734 | --453 |
| -Total interest expense | --0 | --38 | --0 | --831 | --0 | ---- | ---- | -66.01%52 | --153 | --0 |
| Non interest income | 179.16%90.08M | 177.18%32.27M | -141.16%-41.81M | 918.96%101.56M | -63.82%9.97M | 270.64%27.55M | -167.40%-16.14M | -39.78%23.95M | 540.51%39.77M | -140.42%-9.03M |
| -Fees and commissions | -18.99%-2.32M | -1.04%-1.95M | -9.67%-1.93M | -48.55%-1.76M | 17.99%-1.19M | 4.78%-1.45M | 1.58%-1.52M | -18.58%-1.54M | 3.40%-1.3M | 10.07%-1.35M |
| -Dividend income | 8.30%18.38M | 24.60%16.97M | 1.00%13.62M | 19.16%13.48M | 38.85%11.31M | 9.78%8.15M | 6.32%7.42M | 4.46%6.98M | -6.91%6.68M | 5.88%7.18M |
| Credit losses provision | ||||||||||
| Non interest expense | ||||||||||
| Selling and administrative expenses | -18.65%342.77K | 16.90%421.37K | 1.42%360.45K | 19.43%355.39K | -4.71%297.56K | 6.92%312.26K | -52.67%292.04K | 159.77%617.05K | -3.51%237.54K | 3.51%246.18K |
| -General and administrative expense | -18.65%342.77K | 16.90%421.37K | 1.42%360.45K | 19.43%355.39K | -4.71%297.56K | 6.92%312.26K | -52.67%292.04K | 159.77%617.05K | -3.51%237.54K | 3.51%246.18K |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 188.09%89.46M | 168.67%31.05M | -144.92%-45.22M | 1,149.75%100.67M | -70.08%8.05M | 263.79%26.93M | -170.44%-16.44M | -40.97%23.34M | 526.28%39.54M | -141.96%-9.27M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 188.09%89.46M | 168.67%31.05M | -144.92%-45.22M | 1,149.75%100.67M | -70.08%8.05M | 263.79%26.93M | -170.44%-16.44M | -40.97%23.34M | 526.28%39.54M | -141.96%-9.27M |
| Net Income continuous operations | 188.09%89.46M | 168.67%31.05M | -144.92%-45.22M | 1,149.75%100.67M | -70.08%8.05M | 263.79%26.93M | -170.44%-16.44M | -40.97%23.34M | 526.28%39.54M | -141.96%-9.27M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 188.09%89.46M | 168.67%31.05M | -144.92%-45.22M | 1,149.75%100.67M | -70.08%8.05M | 263.79%26.93M | -170.44%-16.44M | -40.97%23.34M | 526.28%39.54M | -141.96%-9.27M |
| Preferred stock dividends | 9.54%13.65M | 44.33%12.46M | 28.25%8.63M | 14.32%6.73M | 35.23%5.89M | 11.08%4.35M | 14.78%3.92M | 13.21%3.41M | -5.25%3.02M | -2.32%3.18M |
| Other under preferred stock dividend | -97.54%117.69K | 2,176.11%4.79M | 68.67%210.61K | 561.00%124.86K | 18.89K | 21.40%-37.93K | 10.60%-48.25K | -12.17%-53.98K | ||
| Net income attributable to common stockholders | 448.48%75.69M | 125.53%13.8M | -157.63%-54.06M | 4,265.16%93.81M | -90.48%2.15M | 210.88%22.57M | -201.99%-20.36M | -45.42%19.96M | 394.82%36.57M | -165.66%-12.4M |
| Diluted earnings per share | 400.00%2.9487 | 121.43%0.5897 | -157.60%-2.7521 | 3,626.67%4.7778 | -92.90%0.1282 | 201.54%1.8051 | -198.11%-1.7778 | -40.98%1.812 | 412.24%3.0701 | -166.92%-0.9833 |
| Basic earnings per share | 400.00%2.9487 | 121.43%0.5897 | -157.60%-2.7521 | 3,626.67%4.7778 | -92.90%0.1282 | 201.54%1.8051 | -198.11%-1.7778 | -40.98%1.812 | 412.24%3.0701 | -166.92%-0.9833 |
| Dividend per share | 0.00%1.0256 | 0.00%1.0256 | 22.45%1.0256 | 2.08%0.8376 | 0.00%0.8205 | 9.09%0.8205 | -5.23%0.7521 | 17.04%0.7936 | 0.00%0.6781 | 0.00%0.6781 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.